Application 204629
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | JARDIANCE | EMPAGLIFLOZIN | TABLET;ORAL | 10MG | Yes | No |
| 002 | JARDIANCE | EMPAGLIFLOZIN | TABLET;ORAL | 25MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204629-001 | JARDIANCE | EMPAGLIFLOZIN | 10MG | TABLET / ORAL | AB | RLD | 2014-08-01 |
| N204629-002 | JARDIANCE | EMPAGLIFLOZIN | 25MG | TABLET / ORAL | AB | RLD, RS | 2014-08-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N204629-001 | AB |
| N204629-002 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204629-001 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | |
| N204629-001 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N204629-001 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | |
| N204629-001 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N204629-001 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | |
| N204629-001 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N204629-001 | 8551957*PED | 2030-04-14 | Pediatric extension | ||
| N204629-001 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N204629-001 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N204629-001 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N204629-001 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N204629-001 | 11090323 | 2034-04-03 | U-3191 | 2021-08-20 | |
| N204629-001 | 11666590 | 2034-04-03 | U-3691 | 2023-10-03 | |
| N204629-001 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | |
| N204629-001 | 11813275 | 2034-04-03 | U-3760 | 2023-12-13 | |
| N204629-001 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N204629-001 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N204629-001 | 12263153 | 2034-04-03 | U-4171 | 2025-04-29 | |
| N204629-001 | 12427162 | 2034-04-03 | U-4287 | 2025-10-17 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4293 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4294 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4295 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4296 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4304 | 2025-10-30 | |
| N204629-001 | 9949997 | 2034-05-17 | U-2292 | 2018-05-15 | |
| N204629-001 | 9949997 | 2034-05-17 | U-3199 | 2018-05-15 | |
| N204629-001 | 9949997 | 2034-05-17 | U-3325 | 2018-05-15 | |
| N204629-001 | 9949998 | 2034-06-11 | U-2290 | 2018-05-15 | |
| N204629-001 | 10258637*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 11090323*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 11813275*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 11833166*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 12433906*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 9949997*PED | 2034-11-17 | Pediatric extension | ||
| N204629-001 | 9949998*PED | 2034-12-11 | Pediatric extension | ||
| N204629-002 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | |
| N204629-002 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N204629-002 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | |
| N204629-002 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N204629-002 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | |
| N204629-002 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N204629-002 | 8551957*PED | 2030-04-14 | Pediatric extension | ||
| N204629-002 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N204629-002 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N204629-002 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N204629-002 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N204629-002 | 11090323 | 2034-04-03 | U-3191 | 2021-08-20 | |
| N204629-002 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N204629-002 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N204629-002 | 12263153 | 2034-04-03 | U-4171 | 2025-04-29 | |
| N204629-002 | 12427162 | 2034-04-03 | U-4287 | 2025-10-17 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4293 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4294 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4295 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4296 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4304 | 2025-10-30 | |
| N204629-002 | 9949997 | 2034-05-17 | U-2292 | 2018-05-15 | |
| N204629-002 | 9949998 | 2034-06-11 | U-2290 | 2018-05-15 | |
| N204629-002 | 10258637*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 11090323*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 11833166*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 12433906*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 9949997*PED | 2034-11-17 | Pediatric extension | ||
| N204629-002 | 9949998*PED | 2034-12-11 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N204629-001 | NPP | 2026-06-20 |
| N204629-001 | I-922 | 2026-09-21 |
| N204629-001 | PED | 2026-12-20 |
| N204629-002 | NPP | 2026-06-20 |
| N204629-002 | PED | 2026-12-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | AB | RLD | 2014-08-01 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | AB | RLD, RS | 2014-08-01 | 3bdfa0b2c4d7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-002 | AB | 1 | c2088c7a36db… |
| 2023-01-26 05:58 UTC | 2023-01 | N204629-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N204629-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N204629-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N204629-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N204629-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N204629-002 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N204629-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N204629-002 | AB | 1 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 7713938*PED | 2027-10-15 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 7579449*PED | 2029-02-01 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 8551957*PED | 2030-04-14 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12115179*PED | 2030-08-11 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12527810*PED | 2033-10-22 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11090323 | 2034-04-03 | U-3191 | 2021-08-20 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11666590 | 2034-04-03 | U-3691 | 2023-10-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11813275 | 2034-04-03 | U-3760 | 2023-12-13 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12263153 | 2034-04-03 | U-4171 | 2025-04-29 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12427162 | 2034-04-03 | U-4287 | 2025-10-17 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12433906 | 2034-04-03 | U-4304 | 2025-10-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12433906 | 2034-04-03 | U-4293 | 2025-10-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12433906 | 2034-04-03 | U-4294 | 2025-10-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12433906 | 2034-04-03 | U-4295 | 2025-10-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12433906 | 2034-04-03 | U-4296 | 2025-10-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 9949997 | 2034-05-17 | U-2292 | 2018-05-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 9949997 | 2034-05-17 | U-3325 | 2018-05-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 9949997 | 2034-05-17 | U-3199 | 2018-05-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 9949998 | 2034-06-11 | U-2290 | 2018-05-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 10258637*PED | 2034-10-03 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11090323*PED | 2034-10-03 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11813275*PED | 2034-10-03 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 11833166*PED | 2034-10-03 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 12433906*PED | 2034-10-03 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 9949997*PED | 2034-11-17 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | 9949998*PED | 2034-12-11 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | 7713938*PED | 2027-10-15 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | 7579449*PED | 2029-02-01 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | d4dbc9d85df4… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | NPP | 2026-06-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | I-922 | 2026-09-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204629-001 | PED | 2026-12-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | NPP | 2026-06-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204629-002 | PED | 2026-12-20 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-001 | NPP | 2026-06-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-001 | I-922 | 2026-09-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-001 | PED | 2026-12-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-002 | NPP | 2026-06-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204629-002 | PED | 2026-12-20 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N204629-001 | NPP | 2026-06-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204629-001 | I-922 | 2026-09-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204629-001 | PED | 2026-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204629-002 | NPP | 2026-06-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204629-002 | PED | 2026-12-20 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N204629-001 | NPP | 2026-06-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204629-001 | I-922 | 2026-09-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204629-001 | PED | 2026-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204629-002 | NPP | 2026-06-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204629-002 | PED | 2026-12-20 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N204629-001 | NPP | 2026-06-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204629-001 | I-922 | 2026-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204629-001 | PED | 2026-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204629-002 | NPP | 2026-06-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204629-002 | PED | 2026-12-20 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-001 | M-82 | 2025-02-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-001 | PED | 2025-08-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-001 | NPP | 2026-06-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-001 | I-922 | 2026-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-001 | PED | 2026-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-002 | NPP | 2026-06-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204629-002 | PED | 2026-12-20 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-001 | M-82 | 2025-02-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-001 | PED | 2025-08-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-001 | NPP | 2026-06-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-001 | I-922 | 2026-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-001 | PED | 2026-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-002 | NPP | 2026-06-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204629-002 | PED | 2026-12-20 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204629-001 | M-82 | 2025-02-24 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jardiance | EMPAGLIFLOZIN | Redpharm Drug | 59ed43d9-b4e0-72a2-e063-6394a90a327d | 2026-08-26 | Warnings, Adverse reactions | 204629 NDA204629 |
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 334f1b3d-5670-6685-e063-6294a90a7e47 | 2026-06-17 | Warnings, Adverse reactions | 204629 NDA204629 |
| Jardiance | EMPAGLIFLOZIN | Cardinal Health 107, LLC | 5777b8a8-ada6-4950-8548-43a1de11f075 | 2026-02-17 | Warnings, Adverse reactions | 204629 NDA204629 55154-0411 55154-0412 |
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 8b6261f6-4bdc-462e-8af1-4064664c62f3 | 2025-10-27 | Warnings, Adverse reactions | 204629 NDA204629 71610-177 |
| Jardiance | EMPAGLIFLOZIN | A-S Medication Solutions | a77214ca-572e-485e-aae9-f7950187e5fb | 2023-08-08 | Warnings, Adverse reactions | 204629 NDA204629 50090-4384 |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 942a82a4-cbbd-4e44-9965-8d03f767912b | 2023-07-24 | Warnings, Adverse reactions | 204629 NDA204629 50090-4492 |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 1782b947-4a72-4feb-a488-1469d9af82bd | 2023-05-03 | Warnings, Adverse reactions | 204629 NDA204629 |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | f2b41c77-0abb-40ee-8578-86a748d0e19e | 2023-05-03 | Warnings, Adverse reactions | 204629 NDA204629 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0152 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0153 | Jardiance | Empagliflozin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 50090-4384 | Jardiance | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4384 | Jardiance | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4384 | Jardiance | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4384 | Jardiance | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4492 | Jardiance | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4492 | JARDIANCE | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4492 | Jardiance | Empagliflozin | A-S Medication Solutions | NDA | Current |
| 55154-0411 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0411 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0411 | Jardiance | Empagliflozin | Cardinal Health 107, LLC | NDA | Current |
| 55154-0411 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0411 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0412 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0412 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0412 | Jardiance | Empagliflozin | Cardinal Health 107, LLC | NDA | Current |
| 55154-0412 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 55154-0412 | Jardiance | Empagliflozin | Cardinal Health | NDA | Current |
| 70518-1986 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-1986 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-1986 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-1986 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-2447 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-2447 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-2447 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 70518-2447 | Jardiance | Empagliflozin | REMEDYREPACK INC. | NDA | Current |
| 71610-177 | Jardiance | Empagliflozin | Aphena Pharma Solutions - Tennessee, LLC | NDA | Current |
| 71610-177 | Jardiance | Empagliflozin | Aphena Pharma Solutions - Tennessee, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83951 | SUPPL | 2025-10-28 |
| 83924 | SUPPL | 2025-10-27 |
| 83923 | SUPPL | 2025-10-27 |
| 75559 | SUPPL | 2023-09-25 |
| 75532 | SUPPL | 2023-09-22 |
| 75438 | SUPPL | 2023-09-13 |
| 75414 | SUPPL | 2023-09-13 |
| 74588 | SUPPL | 2023-06-22 |
| 74575 | SUPPL | 2023-06-21 |
| 73523 | SUPPL | 2023-02-16 |
| 72380 | SUPPL | 2022-10-17 |
| 72379 | SUPPL | 2022-10-17 |
| 72337 | SUPPL | 2022-10-14 |
| 70618 | SUPPL | 2022-03-28 |
| 70617 | SUPPL | 2022-03-28 |
| 70580 | SUPPL | 2022-03-22 |
| 70277 | SUPPL | 2022-02-28 |
| 70276 | SUPPL | 2022-02-28 |
| 70270 | SUPPL | 2022-02-28 |
| 68418 | SUPPL | 2021-08-19 |
| 68417 | SUPPL | 2021-08-19 |
| 68411 | SUPPL | 2021-08-19 |
| 67800 | SUPPL | 2021-06-15 |
| 67799 | SUPPL | 2021-06-15 |
| 67782 | SUPPL | 2021-06-14 |
| 67781 | SUPPL | 2021-06-14 |
| 67780 | SUPPL | 2021-06-14 |
| 65830 | SUPPL | 2021-01-06 |
| 65829 | SUPPL | 2021-01-06 |
| 64668 | SUPPL | 2020-09-24 |
| 64667 | SUPPL | 2020-09-24 |
| 64666 | SUPPL | 2020-09-24 |
| 64011 | SUPPL | 2020-07-22 |
| 61672 | SUPPL | 2020-01-27 |
| 61664 | SUPPL | 2020-01-27 |
| 61663 | SUPPL | 2020-01-27 |
| 57065 | SUPPL | 2018-12-30 |
| 57018 | SUPPL | 2018-12-26 |
| 57017 | SUPPL | 2018-12-26 |
| 56175 | SUPPL | 2018-10-30 |
| 56158 | SUPPL | 2018-10-29 |
| 56157 | SUPPL | 2018-10-29 |
| 50715 | SUPPL | 2017-12-15 |
| 50692 | SUPPL | 2017-12-14 |
| 46031 | SUPPL | 2016-12-06 |
| 46011 | SUPPL | 2016-12-05 |
| 10369 | SUPPL | 2016-07-12 |
| 19580 | SUPPL | 2016-03-22 |
| 10368 | SUPPL | 2016-03-22 |
| 19579 | SUPPL | 2016-03-04 |
| 32575 | SUPPL | 2016-02-09 |
| 32576 | SUPPL | 2015-12-08 |
| 19581 | SUPPL | 2015-12-08 |
| 40402 | SUPPL | 2015-07-01 |
| 40401 | SUPPL | 2015-07-01 |
| 19578 | SUPPL | 2015-07-01 |
| 32574 | SUPPL | 2015-06-30 |
| 32573 | SUPPL | 2015-06-30 |
| 10367 | SUPPL | 2015-06-30 |
| 43470 | ORIG | 2014-09-09 |
| 24474 | ORIG | 2014-09-09 |
| 32572 | ORIG | 2014-08-04 |
| 19577 | ORIG | 2014-08-04 |